Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners
1 2 3 4 5 6 7 8 9 10 ... Total pages:250  Next 

Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part four)


(By Dave Silver, BiotechEast)

(Part four of a four-part series)

10 July, 2014
Synergies, compatibilities and opportunities

A: Synergies in specific therapeutic areas
There are interesting similarities in the research expertise in both countries, setting up synergies that can only encourage closer collaborations. For example, research into cancer therapeutics is the focus of both countries, as is immunology. And the intersection of the two in the exciting new field of cancer immunotherapy is another where the two countries have world-class scientists, discovery and development taking place.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part three)


(By Dave Silver, BiotechEast)

(Part three of a four-part series)

10 July, 2014
New funding initiatives to boost number and strength of startups
Perhaps the biggest hurdle standing in the way of success for New Zealandís burgeoning bioscience sector, both for startups and ones whoíve been around for longer, is the lack of access to sufficient funding. New Zealandís local VC industry is relatively inexperienced and risk averse, and funding that does become available through such channels is often insufficient. And going public in New Zealand (or Australia, its closest neighbor) is not the same money-raising exercise it can be in countries with larger populations and capital markets. As a result, New Zealand biotech startups stay relatively small and underfunded and with pipelines a little too shallow; growth potential is being held back as a result.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part two)


(By Dave Silver, BiotechEast)

(Part two of a four-part series)

10 July, 2014
New Zealand's strengths in drug discovery a good fit for Taiwan
The business model underpinning the biotechnology industry is the value chain, where a piece of intellectual propertyĖsuch as a new drug moleculeĖchanges hands as it moves along the chain, undergoing development and gaining value at each step along the way until it reaches the market. And for small countries such as New Zealand and Taiwan and in particular when it comes to drug development, success depends on finding a niche position in the chain where value can be captured and added to before passing it on to the next player.




Life Science News

(Taiwan) Now's the time for biotech: Taiwan offers opportunities for New Zealand companies and researchers amidst backdrop of ANZTEC and increasing bilateral business ties (Part one)


(By Dave Silver, BiotechEast)

(Part one of a four-part series)

10 July, 2014
With the catalyst that was the signing on December 1, 2013 of ANZTEC* a free trade agreement between New Zealand and Taiwan and the first signed between Taiwan and an OECD economy, two-way trade between the two countries is already up over 30 percent. While there are opportunities across the spectrum of goods and services, itís biotechnology that may be best placed to take advantage of this agreement. With complementary capabilities, and coupled with the fact that both are small countries with innovative and entrepreneurial drive in their collective DNA, New Zealand and Taiwan have already begun forging collaborations that could significantly boost the bio-industries of both countries.




Life Science News

(Taiwan) GNT of Taiwan and Penderyn Distillery of Wales launch gold flake whisky for sale in Taiwan and China


(BiotechEast staff)

2 September, 2014
Taiwan's Gold NanoTech Inc. (GNT) and Penderyn Distillery, Wales' only distillery, have teamed up to produce a special product to be sold in Taiwan and China; Penderyn Welsh single malt whisky laced with edible gold flakes. The two companies will hold a ceremony on the distillery premises on Tuesday, signing a Memorandum of Understanding (MOU) agreement to formalize their cooperation.




Life Science News

(Taiwan) New Zealand-Taiwan joint research project funding announced


(BiotechEast staff)
21 August, 2011

The Royal Society of New Zealand, a science and technology funding and promotion body, announced it has begun accepting applications for a NZ$50,000 grant to fund New Zealand researchers to travel to Taiwan and Taiwanese researchers to travel to New Zealand to collaborate on joint research programs in life sciences or other such advanced technologies.




Life Science News

(Taiwan) BioBusiness Asia conference to open BioTaiwan 2014 series of events


(BiotechEast staff)

2 July, 2014
Taipei's annual festival of life science-focused events, BioTaiwan 2014, will kick off with the two-day BioBusiness Asia conference (BBA) on July 23rd at the Grand Hyatt Taipei.




Life Science News

Vitafoods Asia 2014 Establishes Itself as the Hub for Business and Learning in Asia


(Press release, Vitafoods Asia)

30 June, 2014
The Asian nutraceutical market has experienced unprecedented growth over the last decade and is well-placed to position itself alongside more developed US and European markets. Now, as China flexes its muscles, emerging markets such as Indonesia burst with opportunity and demand for nutraceuticals, and dietary supplements in densely populated countries such as India show no signs of abating, all eyes are on Asia as the region establishes itself as a business hub for new product development.




Life Science News

Exclusive learning and networking opportunities at the new Vitafoods Asia Conference 2014


(Press release, Vitafoods Asia 2014)

18 June, 2014
Nutraceutical experts from around the world will lead the new Vitafoods Asia Conference, which takes place alongside Vitafoods Asia (3-4 September, 2014, AsiaWorld-Expo, Hong Kong), the only event in Asia exclusively dedicated to the nutraceutical, functional and fortified food & drinks sector.




Life Science News

Vitafoods Asia 2014: Pan-Asia's only nutraceutical exhibition returns with leading innovators and new in-depth conference


(Press release, Vitafoods Asia 2014)

12 June, 2014
Returning in 2014, Vitafoods Asia (3-4 September, AsiaWorld-Expo, Hong Kong) is the only Pan-Asian exhibition dedicated exclusively to the nutraceutical industry and with more exhibitors, features and presentations from industry leaders than previous editions, the show is expected to be bigger than ever.




Events



Sponsors

Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy